Figure 1. Diagram showing the contribution of KRAS and BRAF to the EGFR pathway.
Activating mutations in both BRAF and KRAS will result in EGFR independent cell proliferation and hence resistance to anti-EGFR antibody treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.